How'd you fix Pear Therapeutics' revenue issues in 2026?
Direct Answer Pear needed to abandon the prescription-digital-therapeutics-as-standalone-drug model and pivot to embedded distribution (CVS-style PBM billing, employer bundles, health system partnerships) while narrowing focus to ONE indica…
Read full answer ↗